Vita Life Sciences Ltd (ASX:VLS) has seen its share price climb 18% over the past quarter. Analysts point to the company's robust Return on Equity and consistent earnings growth as key drivers behind the rally, outperforming broader industry benchmarks.
In a rare alignment of priorities, the administrations of U.S. President Donald Trump and Colombian President Gustavo Petro have jointly sanctioned a manhunt for three of Colombia's most powerful narcotics kingpins, disrupting fragile peace processes and escalating regional security efforts.
Using advanced genetic genealogy, authorities have identified the remains of Jeanette Marcotte, a Canadian woman missing since the early 1980s, found in a Florida wooded area. The case raises possible links to the infamous 'Vampire Rapist,' John Crutchley.
Under sharp questioning from Rep. Sean Casten, Scott Bessent, a key economic advisor to the Trump campaign, walked back his past written assertion that tariffs are 'inflationary,' correcting his testimony from earlier in the same hearing.
STERIS plc's shares have climbed over 20% in the past year, prompting a critical valuation debate. While a discounted cash flow model suggests the stock is fairly priced, its elevated P/E ratio compared to industry peers raises questions about its current premium. We examine the metrics and investor narratives shaping the outlook for this healthcare infrastructure leader.
Backed by major investors, Zipline plans U.S. metro expansions as proposed federal regulations pave the way for widespread beyond-visual-line-of-sight drone operations, accelerating a shift in last-mile logistics.
A wave of selling swept through global technology stocks this week, erasing hundreds of billions in market value, as conflicting fears over artificial intelligence's disruptive potential and its near-term demand rattled Wall Street.
After a rigorous, two-year search involving over 100 candidates, Disney's board has selected parks veteran Josh D'Amaro to succeed Bob Iger. The meticulous process, led by Chairman James Gorman, aimed to avoid the pitfalls of past succession failures and ensure a stable handoff for the entertainment giant.
TerraCom Limited's non-executive chairman has significantly increased his investment in the company, signaling insider confidence as the coal miner navigates a challenging market.
Amidst a cautious market environment shaped by RBA rate hikes and global tech volatility, a closer look reveals resilient opportunities. We examine three ASX-listed penny stocks—from biotech to mining—that are navigating the headwinds with distinct strategies and potential.
Ad tech firm Consumable Inc. has acquired Radio.com and Mark Cuban's Fireside platform, merging them to build a new streaming service aimed at empowering creators in an AI-dominated media landscape, backed by a multi-million-dollar artist fund.
President Trump's selection of former Fed Governor Kevin Warsh to lead the Federal Reserve marks a decisive shift toward market-driven policy and reinforces central bank independence, with immediate ripple effects across currency and commodity markets.
Darden Restaurants announces the phase-out of its Bahama Breeze brand, with all remaining locations nationwide to close or be rebranded by 2026. Florida, home to the most outlets, will see significant changes.
As Bitcoin struggles to hold the $73,000 level, decentralized prediction platform Polymarket shows traders are betting heavily on a further drop to $65,000 this year, reflecting a stark shift in sentiment from earlier bullish forecasts.
Reason's Robby Soave argues the mass release of Jeffrey Epstein-related files has fueled a partisan witch hunt, prioritizing political smears over justice and threatening civil liberties.
With Jerome Powell's term as Federal Reserve Chair set to conclude in May 2026 and Kevin Warsh nominated as his successor, market strategists are eyeing potential winners in Financials, Small-Caps, and Real Estate ETFs.
Yum! Brands announces the closure of roughly 3% of Pizza Hut's U.S. restaurants in H1 2026 amid a strategic review that could lead to a sale, as the iconic chain grapples with shifting consumer habits and domestic sales decline.
Eli Lilly's blockbuster drugs Mounjaro and Zepbound have propelled it to a commanding lead in the lucrative weight-loss and diabetes market, while rival Novo Nordisk warns of declining sales in 2026, sending its shares tumbling.
Sugar futures extended their decline this week, with prices hitting multi-year lows in London, as analysts project persistent global surpluses for the coming seasons, driven by robust harvests in Brazil and India.
CNBC's Jim Cramer offered a blunt assessment of Dillard's Inc. (NYSE: DDS) when pressed by a viewer, stating he lacks sufficient knowledge of the department store chain to recommend it, highlighting the challenges facing traditional retailers.
